Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial-Reference-Cited by-同舟云学术

Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial

Published:2006-07 Issue:1 Volume:152 Page:149-154
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Rajagopal Vivek,Lincoff A. Michael,Cohen David J.,Gurm Hitinder S.,Hu Tingfei,Desmet Walter J.,Kleiman Neal S.,Bittl John A.,Feit Frederick,Topol Eric J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty;The EPIC Investigators;N Engl J Med,1994

2. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization;The EPILOG Investigators;N Engl J Med,1997

3. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes;Bhatt;JAMA,2000

4. Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study was supported by Centocor, Inc., Malvern, Pennsylvania.

5. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention;Anderson;J Am Coll Cardiol,2001

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

2. Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome;JACC: Cardiovascular Interventions;2015-01

4. Clinical review: Bleeding - a notable complication of treatment in patients with acute coronary syndromes: incidence, predictors, classification, impact on prognosis, and management;Critical Care;2013

5. Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus;Herz;2012-03-30